NeuroSearch A/S - Product Pipeline Review - Q1 2011

Global Markets Direct, March 2011, Pages: 77

NeuroSearch A/S – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “NeuroSearch A/S - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- NeuroSearch A/S - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NeuroSearch A/S human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of NeuroSearch A/S with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the NeuroSearch A/S’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate NeuroSearch A/S’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of NeuroSearch A/S in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the NeuroSearch A/S’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with NeuroSearch A/S.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of NeuroSearch A/S and identify potential opportunities in those areas.

List of Tables
List of Figures
NeuroSearch A/S Snapshot
NeuroSearch A/S Overview
Key Information
Key Facts
NeuroSearch A/S – Research and Development Overview
Key Therapeutic Areas
NeuroSearch A/S – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
NeuroSearch A/S – Pipeline Products Glance
NeuroSearch A/S – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
NeuroSearch A/S Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
NeuroSearch A/S–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
NeuroSearch A/S – Drug Profiles
Huntexil
Product Description
Mechanism of Action
R&D Progress
Huntexil
Product Description
Mechanism of Action
R&D Progress
NS2330
Product Description
Mechanism of Action
R&D Progress
ASP2314
Product Description
Mechanism of Action
R&D Progress
NSD-721
Product Description
Mechanism of Action
R&D Progress
NSD-788
Product Description
Mechanism of Action
R&D Progress
Ordopidine
Product Description
Mechanism of Action
R&D Progress
Seridopidine
Product Description
Mechanism of Action
R&D Progress
NSD-726
Product Description
R&D Progress
NSD-761
Product Description
Mechanism of Action
R&D Progress
NSD-847
Product Description
Mechanism of Action
R&D Progress
NSD-867
Product Description
Mechanism of Action
R&D Progress
NeuroSearch A/S – Pipeline Analysis
NeuroSearch A/S – Pipeline Products by Therapeutic Class
NeuroSearch A/S - Pipeline Products By Target
NeuroSearch A/S – Pipeline Products by Route of Administration
NeuroSearch A/S – Pipeline Products by Molecule Type
NeuroSearch A/S – Recent Pipeline Updates
NeuroSearch A/S - Dormant Projects
NeuroSearch A/S - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
NS2330
NS2389
NS2710
NSD-644
NeuroSearch A/S – Company Statement
NeuroSearch A/S – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Mar 08, 2010: NeuroSearch Reports New Findings From MermaiHD Phase III Study With Huntexil
Feb 11, 2010: NeuroSearch Presents Additional Data From MermaiHD Study With Huntexil
Aug 25, 2009: NeuroSearch Achieves Approval For Huntexil As Brand Name For Pridopidine
Aug 04, 2009: NeuroSearch Successfully Advances NSD-721 For Treatment Of Social Anxiety Disorder And Receives EUR 5 million In Equity Financing Under The Alliance With GlaxoSmithKline
Oct 27, 2008: NeuroSearch Announces That The First Huntington Patients Have Been Treated In The U.S. HART Study As Part Of The Ongoing Pivotal Clinical Program With ACR16
Jun 26, 2008: NeuroSearch Successfully Completes Phase I With ACR325 And Announces The Decision To Progress Development Into Phase II Proof-Of-Concept Studies In Parkinson’s disease and Bipolar Disorder
Mar 31, 2008: NeuroSearch Initiates Clinical Phase I Study With NSD-788 For The Treatment Of Anxiety And Depression
Mar 31, 2008: NeuroSearch Initiates Clinical Phase I Study With NSD-788 For The Treatment Of Anxiety And Depression
Dec 18, 2007: NeuroSearch Initiates Clinical Phase I Study With ACR343 As A Potential New Treatment For Parkinson’s Disease
Dec 03, 2007: Neurosearch Initiates Clinical Phase I Study With NSD-644 As A Potential New Pain Treatment
Financial Deals Landscape
NeuroSearch A/S, Deals Volume Summary, 2004 to YTD 2011
NeuroSearch A/S, Deals Summary By Region, 2004 to YTD 2011
NeuroSearch A/S, Deals Summary, 2004 to YTD 2011
NeuroSearch A/S Detailed Deal Summary
Asset Purchase
PainCeptor Acquires Patent Rights From NeuroSearch
Acquisition
NeuroSearch Acquires A. Carlsson Research
NeuroSearch Sells Stake In Bavarian Nordic
NeuroSearch Acquires Stake In PainCeptor Pharma
Venture Financing
NsGene Secures $4 Million In Venture Financing
Equity Offering
NeuroSearch Completes Public Offering Of $86 Million
NeuroSearch Completes Private Placement Of $17.6 Million
NeuroSearch Completes Rights Offering For $149 Million
NeuroSearch Completes Rights Offering Of $69 million
NeuroSearch Completes Private Placement Of $1.34 Million
NeuroSearch Partners With Janssen Pharmaceutica
NeuroSearch Enters Into Drug Discovery Agreement With Eli Lilly
NeuroSearch Expands Its Agreement With GlaxoSmithKline
GlaxoSmithKline Enters Into An Agreement With NeuroSearch
GlaxoSmithKline Expands Collaboration Agreement With NeuroSearch
NeuroSearch Expands Co-Development Agreement With TopoTarget
NeuroSearch Enters Into Agreement With Karolinska University Hospital
NeuroSearch Enters Into Co-Development Agreement With TopoTarget
NeuroSearch Terminates Licensing Agreement With Astellas Pharma For The Rights Of ACR16
Licensing Agreements
Boehringer Terminates Licensing Agreement With NeuroSearch
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NeuroSearch A/S – Pipeline by Therapy Area and Indication, 2011
NeuroSearch A/S – Pipeline by Stage of Development, 2011
NeuroSearch A/S – Monotherapy Products in Pipeline, 2011
NeuroSearch A/S – Phase III, 2011
NeuroSearch A/S - Phase II, 2011
NeuroSearch A/S - Phase I, 2011
NeuroSearch A/S - Pipeline By Therapeutic Class, 2011
NeuroSearch A/S - Pipeline By Target, 2011
NeuroSearch A/S – Pipeline By Route of Administration, 2011
NeuroSearch A/S – Pipeline By Molecule Type, 2011
NeuroSearch A/S – Recent Pipeline Updates, 2011
NeuroSearch A/S - Dormant Developmental Projects, 2010
NeuroSearch A/S - Discontinued Pipeline Products, 2010
NeuroSearch A/S, Subsidiaries
NeuroSearch A/S, Deals Summary, 2004 to YTD 2011
NeuroSearch A/S, Deals Summary by Region, 2004 to YTD 2011
NeuroSearch A/S, Deals Summary, 2004 to YTD 2011

List of Figures
NeuroSearch A/S – Pipeline by Therapy Area and Indication, 2011
NeuroSearch A/S – Pipeline by Stage of Development, 2011
NeuroSearch A/S – Monotherapy Products in Pipeline, 2011
NeuroSearch A/S – Pipeline By Therapeutic Class, 2011
NeuroSearch A/S - Pipeline By Target, 2011

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Analysis of Google Inc
• Priceline - Company Profile
• Google
• Yahoo! - Company Profile - Little to Show for the New Strategy
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Adjacent player profile: Google
• SunGard - Profile - US
• Google - Adapting to Mobile, Margin Risk